Table 2.
The most common drugs implicated in drug-induced liver injury cases (drugs with n ≥ 5) in both the discovery sample and in the individuals available in the Drug-Induced Liver Injury Network replication cohort
N (%) |
||
---|---|---|
Drugs | Discovery sample |
Replication sample |
Amoxicillin/clavulanate | 208 (26.6) | 42 (13.7) |
Flucloxacillin | 75 (9.6) | 0 (0.0) |
Diclofenac | 30 (3.8) | 4 (1.3) |
Nitrofurantoin | 24 (3.1) | 15 (4.9) |
Isoniazid | 17 (2.2) | 7 (2.3) |
Sulfamethoxazole/trimethoprim | 14 (1.8) | 14 (4.6) |
Valproic acid | 13 (1.7) | 2 (0.6) |
Nimesulide | 12 (1.5) | 0 (0.0) |
Minocycline | 10 (1.3) | 17 (5.5) |
Celecoxib | 8 (1.0) | 1 (0.3) |
Flucloxacillin and amoxicillin/ clavulanate |
8 (1.0) | 0 (0.0) |
Ciprofloxacin | 7 (0.9) | 9 (2.9) |
Phenytoin | 7 (0.9) | 1 (0.3) |
Azathioprine | 6 (0.8) | 5 (1.6) |
Duloxetine | 6 (0.8) | 0 (0.0) |
Telithromycin | 6 (0.8) | 0 (0.0) |
Atorvastatin | 5 (0.6) | 3 (1.0) |
Simvastatin | 5 (0.6) | 4 (1.3) |
All other drugs and combinations | 322 (41.1) | 183 (59.6) |